Inventor · disambiguated record
Dehua Huang
Also filed as: HUANG DEHUA
45 granted patents·14 pending applications·540 citations·filing 1999–2025
98Inventor score
Top patents by PatentIndex Score
59 records- 0198US7981893B2Heteroaryl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2007·Granted Jul 19, 2011·90 cites·10 claims
- 0297US9512124B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Dec 6, 2016·32 cites·60 claims
- 0396US11634407B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Apr 25, 2023·5 cites·66 claims
- 0496US9737541B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2016·Granted Aug 22, 2017·12 cites·52 claims
- 0595US8372976B2Methods of treatment comprising the administration of heteroaryl compoundsSIGNAL PHARM LLC·Filed 2011·Granted Feb 12, 2013·40 cites·1 claims
- 0695US6291677B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Sep 18, 2001·51 cites·13 claims
- 0793US11739075B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Aug 29, 2023·3 cites·17 claims
- 0893US11560371B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Jan 24, 2023·3 cites·18 claims
- 0993US6313107B1Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·44 cites·21 claims
- 1091US6252090B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Jun 26, 2001·28 cites·24 claims
- 1189US9556126B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2014·Granted Jan 31, 2017·10 cites·32 claims
- 1288US10398700B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2018·Granted Sep 3, 2019·2 cites·11 claims
- 1387US10149849B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2017·Granted Dec 11, 2018·2 cites·3 claims
- 1486US9156798B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Oct 13, 2015·5 cites·30 claims
- 1586US8609852B2Thiazolyl mGluR5 antagonists and methods for their useCOSFORD NICHOLAS D·Filed 2012·Granted Dec 17, 2013·12 cites·2 claims
- 1686US7462619B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2005·Granted Dec 9, 2008·5 cites·2 claims
- 1786US6720423B2Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptorsALLERGAN INC·Filed 2002·Granted Apr 13, 2004·41 cites·54 claims
- 1886US6387892B1Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2001·Granted May 14, 2002·18 cites·6 claims
- 1985US10940152B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2020·Granted Mar 9, 2021·1 cites·27 claims
- 2085US6495552B2Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAIALLERGAN INC·Filed 2001·Granted Dec 17, 2002·16 cites·63 claims
- 2184US10646493B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2019·Granted May 12, 2020·1 cites·20 claims
- 2284US2023158035A1Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2023·Application pending·0 cites
- 2383US9428509B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2014·Granted Aug 30, 2016·6 cites·32 claims
- 2483US9346812B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2014·Granted May 24, 2016·6 cites·30 claims
- 2583US6369225B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Apr 9, 2002·13 cites·26 claims
- 2682US11358952B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted Jun 14, 2022·1 cites·21 claims
- 2782US7879882B2Thiazolyl mglur5 antagonists and methods for their useMERCK SHARP & DOHME·Filed 2005·Granted Feb 1, 2011·4 cites·2 claims
- 2881US6387951B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted May 14, 2002·8 cites·11 claims
- 2981US6359135B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2001·Granted Mar 19, 2002·8 cites·18 claims
- 3080US2024217955A1Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2024·Application pending·0 cites
- 3179US9783505B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2016·Granted Oct 10, 2017·2 cites·29 claims
- 3279US6399774B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2001·Granted Jun 4, 2002·6 cites·9 claims
- 3378US2025188056A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2024·Application pending·0 cites
- 3477US11945804B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 3576US12103920B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2023·Granted Oct 1, 2024·0 cites·15 claims
- 3676US6855512B2Methods for identifying inhibitors of cytochrome P450RAIALLERGAN INC·Filed 2002·Granted Feb 15, 2005·6 cites·7 claims
- 3776US6531599B2Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2001·Granted Mar 11, 2003·4 cites·13 claims
- 3876US6093838AAmines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activityALLERGAN SALES INC·Filed 1999·Granted Jul 25, 2000·39 cites·26 claims
- 3975US11590139B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2021·Granted Feb 28, 2023·0 cites·52 claims
- 4073US7365074B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2004·Granted Apr 29, 2008·5 cites·2 claims
- 4172US12227490B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2023·Granted Feb 18, 2025·0 cites·18 claims
- 4272US7569592B2Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2002·Granted Aug 4, 2009·6 cites·2 claims
- 4372US2025320183A1Modulators of BCL6 as Ligand Directed DegradersCELGENE CORP·Filed 2025·Application pending·0 cites
- 4468US12404239B2Modulators of BCL6 as ligand directed degradersCELGENE CORP·Filed 2023·Granted Sep 2, 2025·0 cites·10 claims
- 4568US8242143B2Thiazolyl mGluR5 antagonists and methods for their useCOSFORD NICHOLAS D·Filed 2011·Granted Aug 14, 2012·1 cites·8 claims
- 4667US7371767B2Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2002·Granted May 13, 2008·3 cites·16 claims
- 4762US7393959B2Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2004·Granted Jul 1, 2008·1 cites·6 claims
- 4861US2025100995A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Application pending·0 cites
- 4959US2024368118A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Application pending·0 cites
- 5059US2024374591A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dehua Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →